**Abstract**

**Introduction:** In this study, we investigated changes in phosphorylation of Mr 32 kDa and ERK1/2 related signaling pathways in rat striatum, which is closely related to development of extrapyramidal symptom, after intraperitoneal injection of risperidone, which is one of the representative atypical antipsychotics, to facilitate understanding of the action mechanism of antipsychotic agents and regulatory mechanism of signal transduction of neuronal cell.

**Methods:** Risperidone (0.5, 2.0 mg/kg) was injected into the Sprague-Dawley rats intraperitoneally and control animals received an equivalent volume of 0.3% tartaric acid. Western blot analysis was carried out to investigate the changes in Mr 32 kDa and ERK1/2 related molecules in response to risperidone treatment.

**Results:** After 15, 30, 60 and 120min from treatment of risperidone (0.5 mg/kg), phosphorylations of MEK1/2 (Ser217/Ser221) and ERK1/2 (Thr202/Tyr204) were not changed, significantly. After 30 min from treatment of risperidone (2.0 mg/kg), phosphorylations of MEK1/2 were increased, significantly. After 120 min from treatment of risperidone (2.0 mg/kg), phosphorylations of ERK1/2 were increased, significantly.

In terms of p90RSK (Thr360/Ser364), phosphorylations were increased after 30 and 60min from treatment of risperidone (2.0 mg/kg).

**Conclusions:** Phosphorylations of ERK1/2, MEK1/2, and p90RSK were not changed after treatment of risperidone 0.5 mg/kg. Phosphorylations of ERK1/2, MEK1/2, and p90RSK after the injection of risperidone 2mg/kg were increased in some sample according to time-course. These findings suggest that risperidone may affect MEK1/2-ERK1/2-p90RSK pathway in the manner of time and dose specificity. In summary, time and dose dependant influence of risperidone on the signal transduction in striatum, which is responsible to the pathophysiology of schizophrenia and action mechanism of antipsychotics, might be related to unique properties of atypical antipsychotics include risperidone.
